BHST Stock — Bioharvest Sciences Inc.

Up next

Q2 2026 earnings call transcript

call held Aug 11, 2026

Latest filings

what the company just filed, in one sentence each

6-K filed Oct 29, 2026

BioHarvest Sciences Inc. will report third quarter 2026 financial results before market opening on Thursday, November 12, 2026, followed by an 8:00 AM Eastern Time conference call and webcast covering results and business operations.

Read the 6-K

40-F filed Mar 31, 2026

Read the 40-F

All filings

Metrics snapshot

Useful current figures from the complete screener profile.

View all 122 metrics

Revenue (TTM)

—

Trailing 12 months

Net income (TTM)

—

Trailing 12 months

Revenue growth YoY

+37.0%

Year over year

Operating margin

-16.2%

Trailing 12 months

P / E (TTM)

—

Trailing earnings

FCF yield

—

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

+30.8%

Year over year · more shares

Price change (1Y)

-82.4%

Trailing year

Short interest

0.4%

Latest settlement · 5.1 days to cover

View all 122 metrics

Equibles Rating

blended score · not investment advice

Overall

Sell

SellHoldBuy

Technical Sell Momentum Weak Sentiment Bullish Fundamentals Fair Quant / Vol Very High

Market backdrop VIX 16.9 · calm Equity put/call 0.54

Technical

price trend

Sell

50 / 200-day cross No cross

Price vs 200-day avg −49%

below

Price vs 50-day avg −3%

below

RSI (14) 48

neutral

MACD trend Positive

52-week position 3%

near low

Momentum

relative strength

Weak

1-month return +11%

trailing

6-month return −58%

trailing

YTD return −68%

this year

Relative strength −62%

vs S&P · 6-mo

Sentiment

smart money

Bullish

Trend (MA cross) No cross

50d $2 › 200d $3 — 200d above 50d

Institutional flow Accumulating

4 of 19 funds reported for Sep 30 · net +45.1K sh shares

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

0.40% of float · ▼ -8.9% MoM · 5.1 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

19 holders — mid 1-yr range

Squeeze score 44

elevated · 0–100

Fundamentals

Fair

Revenue growth +37%

Y/Y

Free cash flow $-9.6M

Quant / Vol

risk profile

Very High

Volatility 65%

annualized · 1-yr

Max drawdown −85%

past year

ATR 8.3%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the Earnings Call filed Aug 11, 2026

full year

Total revenue $37M – $40M

prior FY $34.51M midpoint +11.6% Y/Y

first five years from beginning of manufacturing

Revenue $180M

Previous outlook earlier release · from the Earnings Call filed May 14, 2026

Still-open targets the latest release did not restate under the same label.

Total CDMO revenue, including inter-company VINIA production · 2026 $12M – $14M

D2C business revenue · 2026 $38M – $42M

Adjusted EBITDA profit (loss) · 2026 $500,000 – $2M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell

2 · 3 · 1

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−49% Bearish

Price vs 50-day avg

−3% Neutral

RSI (14)

48 Neutral

MACD trend

Positive Bullish

52-week position

3% Bearish

Market signals — smart money & positioning

Bullish · 2 of 6

Trend (MA cross) No cross

50d $2 › 200d $3 — 200d above 50d

Institutional flow Accumulating

4 of 19 funds reported for Sep 30 · net +45.1K sh shares

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

0.40% of float · ▼ -8.9% MoM · 5.1 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

19 holders — mid 1-yr range

Price context

position in its 52-week range

Range low $1 Now $2 · 3% Range high $10

vs 200-day avg -49% vs 50-day avg -3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Packaged Foods — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
BHST Bioharvest Sciences Inc. this stock	$39.90M	-68.0%	+37.0%	—	0.4%
JBS Jbs N.V.	$39.01B	-15.7%	—	—	1.3%
KHC Kraft Heinz Co	$28.29B	-1.4%	-0.1%	—	8.2%
GIS General Mills Inc	$17.67B	-28.3%	+4.1%	—	7.1%
SJM J M SMUCKER Co	$13.44B	+29.1%	+3.7%	—	3.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

19

% held: 7.6%
Reported: 4 of 19
Top holder: Alyeska Investment Group,…

Held Float

View

Held by Funds

Fund positions

1

View

Short & Settlement

Short Interest Falling

Shares short

90.2K

Days to cover: 5.1d
Change: -8.8K sh

View

Short Volume

Short vol %

74%

As of: Oct 29, 2026

Short Total

View

Fails to Deliver

FTD shares

10.9K

Value: $23.5K
As of: Aug 4, 2026

View

Off-Exchange

Off-exchange %

35.9%

Week of: Sep 21, 2026

Off-exch Lit

View

Financials

Revenue (FY)

$34.5M

Net income (FY): $-11.1M

View

Filings

SEC Filings

Latest

6-K

Filed: Oct 29, 2026
This year: 34

BioHarvest Sciences Inc. will report third quarter 2026 financial results before market opening on Thursday, November 12, 2026, followed by an 8:00 AM Eastern Time conference call and webcast covering results and business operations.

View

Exempt Offerings

Offering

$401.3K

Filed: Oct 6, 2025

View

Earnings & Events

Webcasts

Last webcast

Sep 15, 2026

View

Investor Relations

	5D	20D	120D	MTD	YTD
BHST	-1.2%	+11.4%	-58.2%	+12.2%	-68.0%
SPY	+0.7%	+0.7%	+4.3%	+0.9%	+12.8%
vs SPY	-1.9%	+10.7%	-62.5%	+11.3%	-80.8%

BHST · Bioharvest Sciences Inc.

Price & Indicators

Up next

Latest filings

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Versus peers

At a glance

Performance